Compare

Agentix Corp. vs Mosaic ImmunoEngineering Inc. vs Adaptin Bio, Inc. vs Brainstorm Cell Therapeutics Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Agentix Corp. AGTX	Mosaic ImmunoEngineering Inc. CPMV	Adaptin Bio, Inc. APTN	Brainstorm Cell Therapeutics Inc. BCLI
Year ended	2026-03-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$485.6K	-$687.8K	-$5.17M	-$10.31M
EPS (Diluted)	-$0.01	-$0.10	-$0.66	-$1.11
Operating cash flow	-$108.5K	-$111.4K	-$4.78M	-$6.97M
Free cash flow	n/a	n/a	n/a	n/a
Cash & equivalents	$771	$3.6K	$459.2K	$29.0K
Total assets	$771	$19.9K	$619.2K	$1.02M
Total liabilities	$3.60M	$7.50M	$2.11M	$11.01M
Shareholders' equity	-$3.60M	-$7.48M	-$1.49M	-$9.98M
Return on year-end equity	n/a	n/a	n/a	n/a
Shares outstanding	40.07M	7.24M	8.66M	11.03M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Agentix Corp.	Mosaic ImmunoEngineering Inc.	Adaptin Bio, Inc.	Brainstorm Cell Therapeutics Inc.
Latest	$0 Ended 2023-03-31	n/a	n/a	n/a
1 year earlier	$1.2K Ended 2022-03-31	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a